ATAP Advocates
Taking a Stand For Patients
existence (1).png

ATAP News

ATAP News


atap

ATAP Advocates 

ATAP Submits CMS Part D Rule Comments

ATAP urges CMS to adopt a policy requiring sponsors to include all price concessions at the point of sale for Medicare beneficiaries. 


 
Orlando-Sentinel-logo-e1465356031137.png

Orlando sentinel

Florida bill would help prevent drug bait and switch

By Dr. Robert Levin, President of the Florida Society of Rheumatology

Mary is a 45-year-old patient in my practice with severe rheumatoid arthritis. She was incapacitated. Her illness prevented her from working, and also made it difficult to dress, cook, do housework and other everyday tasks that most of us take for granted.


Florida_House_Seal.svg.png

Florida house of representatives

ATAP Chair Dr. Levin Testifies Before Florida House Subcommittee on PBMS

On December 6, ATAP Chair Dr. Robert Levin testified before the Florida House Health and Innovation Subcommittee on the impact deceptive PBM practices have on patient care. “I went to medical school… I know what the patient has and what’s best for my patient. Unfortunately, the decision-making of what prescriptions are available for our patients has been taken out of my hands,” he said. “The patients are expecting that I’m looking out for them…and [I’m] not having some third-party looking over my shoulder telling me what to do.”


ATAP Logo Final (2).png

ATAp Advocates

ATAP Sends Letter to House Committee on Energy and Commerce Subcommittee on Health regarding PBMs

We thank the Subcommittee for scheduling today’s hearing entitled “Examining the Drug Supply Chain.” ATAP was formed on a shared concern that PBMs play an increasingly harmful role in our supply chain.


ATAP Logo Final (2).png

ATAP Advocates

ATAP Sends Letter to Congress Supporting CMS Pass-Through Policy

We urge Congress to encourage CMS to adopt a policy requiring sponsors to include price concessions at the point of
sale for Medicare beneficiaries.


ATAP Logo Final (2).png

ATAP Advocates

ATAP Responds to Federal Innovation Center Request for Information

In a letter submitted to the Centers for Medicare and Medicaid Services (CMS), the Alliance for Transparent and Affordable Prescriptions (ATAP) urged the agency to address the increasingly harmful role of pharmacy benefit managers (PBMs) in the prescription drug delivery system.   


ATAP Logo Final (2).png

ATAP Advocates

Alliance for Transparent & Affordable Prescriptions Adds Three More Organizations

The Lupus and Allied Diseases Association, American Bone Health, and the Tennessee Rheumatology Society became the newest members of the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the practices of pharmacy benefit managers (PBMs) driving up drug costs.  


ATAP Logo Final (2).png

ATAP Advocates

Two Organizations Join Alliance for Transparent & Affordable Prescriptions

Today, the North Carolina Rheumatology Association (NCRA) and the U.S. Pain Foundation became the newest members of the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the practices of pharmacy benefit managers (PBMs) driving up drug costs.  


150635859221796.png

The Center for Biosimilars

PBMs: The Biosimilar Blockade

By Angus Worthing, MD, FACR, FACP

With 5 rheumatology biosimilars already approved by the FDA, and dozens more in the pipeline, the landscape of the rheumatology drug market is on the cusp of a major shift. Biosimilars were created to bring notoriously expensive biologic drugs to patients at lower prices. In theory, they increase access to life-changing, even life-saving, treatments. As a practicing rheumatologist in downtown Washington, DC, I observe firsthand the power of biologics to bring relief to patients suffering from crippling diseases of the joints.


ATAP Advocates

Rheumatology Groups Join Alliance for Transparent & Affordable Prescriptions

The Association of Women in Rheumatology (AWIR), National Organization of Rheumatology Managers (NORM), and Rheumatology Nurses Society (RNS) announced today that they have joined the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the role of pharmacy benefit managers (PBMs) in driving up drug costs.


logo

atap advocates

State Rheumatology Organizations Join Alliance for Transparent & Affordable Prescriptions

The Florida Society of Rheumatology, New York State Rheumatology Society, and California Rheumatology Alliance today became the newest members of the Alliance for Transparent & Affordable Prescriptions (ATAP), a new coalition of provider and patient groups concerned about the role of pharmacy benefit managers (PBMs) in driving up drug costs.


Capture.PNG

Business wire

Leading Health Organizations Announce Launch of Alliance for Transparent & Affordable Prescriptions

Health leaders today announced the launch of the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the practices of pharmacy benefit managers (PBMs) driving up drug costs.  


150100261219262.png

Tallahassee Democrat

Levin: Patients deserve access to the right meds

By Dr. Robert Levin, President of the Florida Society of Rheumatology

Over my 28 years as a practicing rheumatologist, I have progressively been denied my authority to prescribe the best medicines for my patients.The problem is a process called “step therapy,” which allows insurance plans to force physicians to prescribe less effective – and cheaper – drugs before they can use the medications they had in mind all along. This is a bad idea, and the Florida Legislature should correct it immediately.